Detalhe da pesquisa
1.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(4): 959-968, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33191481
2.
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(8): 2141-2142, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34160650
3.
Aggressive natural killer cell leukemia associated with hemophagocytic lymphohistiocytosis
Blood
; 128(19): 2370, 2016 11 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28829111
4.
Aggressive natural killer cell leukemia associated with hemophagocytic lymphohistiocytosis.
Blood
; 128(19): 2370, 2016 11 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28829754
5.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Lancet Haematol
; 7(1): e28-e39, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31606445